We observed strong effects of CDK11 loss on melanoma viability, clonal survival, and tumorsphere formation 96 h or longer after CDK11 downregulation; however, relatively modest effects of CDK11 loss on classical melanoma growth pathways were seen at the protein expression level. This evidence concerns the gene CDK19 and melanoma.